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Abstract
Background. Previous studies provide inconsistent data on whether postoperative delirium (POD) is a risk factor for postop-
erative cognitive decline (POCD). We thus investigated the relationship between POD and cognitive change after cardiac sur-
gery and assessed the relationship between preoperative cognitive domain scores and POD.
Methods. Postoperative delirium was assessed with the Confusion Assessment Method (CAM) adapted for the intensive care
unit and the conventional CAM accompanied by chart review. Cognitive function was assessed with a neuropsychological
test battery before elective cardiac surgery and 1 month and 1 yr afterwards. Cognitive change was calculated using the
Reliable Change Index (RCI). Multiple linear regression was used to adjust for confounding.
Results. Of the 184 patients who completed baseline assessment, 23 (12.5%) developed POD. At 1 month, the decline in cog-
nitive performance was worse in patients with POD [median composite RCI 1.00, interquartile range (IQR) 1.67 to 0.28]
than in patients without POD (RCI 0.04, IQR 0.70 to 0.63, P¼0.02). At 1 yr, both groups showed cognitive improvement on
average compared with baseline (POD patients median composite RCI 0.25, IQR 0.42 to 1.31, vs non-POD patients RCI 0.92,
IQR 0.18–1.53; P¼0.08). Correction for differences in age and level of education did not change the results. Patients with POD
performed less well than patients without POD on the preoperative Trailmaking test part A (P¼0.03).
Conclusions. Postoperative delirium is independently associated with cognitive decline 1 month after surgery, but cognitive
performance generally recovers in 1 yr. Patients with a predisposition to POD can be identified before surgery by worse per-
formance in an attention task.
Clinical trial registration. NCT00293592.
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Transient postoperative cognitive decline (POCD) and postopera-
tive delirium (POD) are relatively common complications after sur-
gery. Patients undergoing cardiac surgery are at high risk for both
conditions because they are relatively old and often have multiple
co-morbidities, including hypertension, diabetes, and previous
ischaemic stroke.1–5 Impaired preoperative overall cognitive func-
tion and low level of education2 increase the risks of both POD and
POCD, but the predisposing cognitive profile for both conditions
has not yet been fully elucidated. There is limited information on
the predictive value of impairment in specific cognitive domains.
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There is inconsistency in the literature on whether POD in-
creases the risk of POCD.6 Two recent studies demonstrated an
association between POD and subsequent POCD in elderly pa-
tients undergoing orthopaedic surgery7 and cardiac surgery.8
Both studies used the Mini-Mental State Examination as a global
measure of cognitive function.9 There is, however, long-
standing consensus that a battery of neuropsychological tests is
required to detect POCD reliably after cardiac surgery.10
Furthermore, it is currently unclear how postoperative cognitive
function evolves over time with respect to the magnitude of the
change, changes in overall cognitive function, and changes in
different cognitive domains.
The primary aim of this study was to examine the relation-
ship between POD and POCD at 1 month after cardiac surgery,
assessed with a battery of neuropsychological tests and based
on a comparison with preoperative neuropsychological test per-
formance. Secondarily, we examined whether POD is associated
with POCD at 1 yr, whether POD differentially affects specific
cognitive domain scores over time, and which preoperative cog-
nitive profile predisposes cardiac surgery patients to develop
POD.
Methods
Study design and participants
For this cohort study, we used a subset of the data from the
Dexamethasone for Cardiac Surgery (DECS) trial registered in
ClinicalTrials.gov (NCT00293592).11
This multicentre, double-blind, placebo-controlled trial
randomized 4494 patients aged 18 yr or older who were
undergoing cardiac surgery with cardiopulmonary bypass to a
single high dose of dexamethasone, 1 mg kg1 i.v. injection with
a maximum of 100 mg, or placebo at the time of induction of an-
aesthesia. The use of intraoperative dexamethasone did not re-
duce the 30 day incidence of major adverse events, a composite
of death, myocardial infarction (MI), stroke, renal failure, or re-
spiratory failure, compared with placebo. The study design and
the primary results have been described in detail previously.11
Data from the present study consist of a subset of the data
from two sub-studies of the DECS study. The first was a sub-
study of the influence of dexamethasone on the incidence of
POD,12 involving the 768 patients enrolled in the DECS trial at the
University Medical Center Utrecht between June 2009 and
November 2011, in whom more elaborate delirium data collection
was conducted. The second was a pre-planned sub-study within
the DECS trial of the effect of dexamethasone on the occurrence
of POCD.13 For this sub-study, 340 patients of the University
Medical Center Utrecht, Utrecht, the Erasmus University Medical
Center, Rotterdam, and Isala Clinics, Zwolle, provided additional
consent (at the time of enrolment in the DECS study) for preop-
erative and follow-up testing of cognitive function. Between
August 2010 and October 2011, 291 patients completed baseline
assessment of their cognitive performance (of the 340 who pro-
vided informed consent, six were unable to complete the baseline
neuropsychological assessments, and 43 could not do so for logis-
tical reasons).13 Of these 291 patients, 184 were also enrolled in
the delirium sub-study. Dexamethasone appeared to have no ef-
fect on POD and POCD.12 13
All 184 patients who participated in and completed both sub-
studies (elaborate delirium screening and cognitive function test-
ing) were included in the present cohort to evaluate the association
between postoperative delirium and cognitive change after cardiac
surgery. Additional exclusion criteria for this additional sub-study
were evident mental illness or significantly impaired vision, hear-
ing, or motor skills (e.g. hemiplegia). Dexamethasone appeared to
have no effect on POD and POCD.12 13 Data on patient, clinical, and
surgical characteristics were prospectively collected in the DECS
trial database.11 The Medical Ethics Committee of the University
Medical Centre Utrecht approved this study, and written informed
consent was obtained from all patients.
To define true cognitive decline beyond natural variation in
test performance, from the cardiology outpatient clinic we re-
cruited as control subjects a group of volunteers with docu-
mented coronary artery or valve pathology but without elective
surgery. In this group, the same neuropsychological test battery
and protocol was used by the same investigators as the trial par-
ticipants, assessing cognition twice with an interval of 1 month.13
Delirium assessment
Delirium was assessed by trained research personnel using a pre-
viously validated method.14 This included daily assessment by a
research nurse using the Confusion Assessment Method (CAM)
adapted for the ICU (CAM-ICU)15 in the ICU setting, the CAM16
when the patient was transferred to the ward, a chart review over
the previous 24 h to identify key words suggestive of delirium
(e.g. confused, agitated, drowsiness, disorientated, delirious),17
the results of twice daily CAM(-ICU) assessments conducted by
the bedside nurse, and the administration of antipsychotic medi-
cation. If any of these indicators were present, the patient was
scored as delirious. Patients who were deemed to be unarousable
as determined by a Richmond Agitation Sedation Scale (RASS)18
score of 4 or 5 were not evaluated for delirium.19 Patients were
assessed on the first 4 days after surgery at a fixed point during
the day whenever possible.
Neuropsychological assessment
Cognitive function was assessed 1 day before surgery (baseline),
at 1 month after cardiac surgery, and at 1 yr follow-up. If pos-
sible, patients were assessed in the hospital by trained research
personnel. In order to maximize the completeness of cognitive
follow-up, patients who were unable to come to the hospital for
follow-up were offered the option to have the neuropsycho-
logical tests administered at their home. Total test time was ap-
proximately 30–40 min, depending on the patient’s speed of
comprehension and execution.
The following tests20 were administered: Corsi block-tapping
task (spatial memory), Rey auditory verbal learning [immediate
recall (short-term verbal memory) and delayed recall (inter-
mediate-term verbal memory)], grooved pegboard (motor skills),
Editor’s key points
• Postoperative delirium and postoperative cognitive dys-
function (POCD) are common complications of cardiac
surgery.
• It is unknown whether they have a similar aetiology
and pathophysiology.
• The authors performed a secondary analysis of the
Dexamethasone for Cardiac Surgery (DECS) study data-
base to investigate associations between the two.
• Among patients who developed postoperative delirium,
POCD at 3 months was more common.
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Trailmaking test [part A (attention) and part B (executive func-
tion)], Digit Span forward and backward (Wechsler Adult
Intelligence Scale, Revised; verbal memory; see Supplementary
Appendix A).
To obtain an overall score of baseline cognitive performance,
we first calculated a z-score for each raw test score of each pa-
tient by subtracting the total group mean from the patient’s indi-
vidual score and dividing the residue by the group SD. In timed
tasks, scores were inverted so that a higher z-score always
indicated better cognitive performance. Then, an overall Z-score
was calculated as the mean of the z-scores of the eight test vari-
ables and used as a baseline composite cognitive outcome meas-
ure. To control for natural variation and practice effects in
cognitive test performance during follow-up, we used the
Jacobson and Truax’ Reliable Change Index (RCI).21 This approach
yields a z-score for every individual test by subtracting from the
follow-up score the baseline test score and the mean change on
that test in the control group and dividing the result by the SD of
the change in the control group. In timed tasks, RCI values were
inverted as described above. For the composite RCI, the sum of
the z-scores of the different tests was divided by the SD of this
sum in the control group.13 Psychometric test scores from the
control group are presented in Supplementary Appendix B.
Study outcomes
The primary study outcome was change in cognitive perform-
ance from baseline to 1 month after surgery. Secondly, cognitive
performance was assessed at 1 yr. In addition, we assessed the
influence of POD on individual cognitive test scores at 1 month
and 1 yr after surgery. Finally, the association between pre-
operative cognitive test performance and the occurrence of POD
was investigated.
Statistical analysis
The sample size of this cohort study was determined by the
available number of 184 patients within the DECS trial in whom
both the presence of POD and cognitive functioning were meas-
ured prospectively. Continuous baseline variables were pre-
sented as mean or median values, depending on distribution,
and compared with Student’s unpaired t-test or the Mann–
Whitney U-test, as appropriate. Binary data were presented as
percentages and analysed using the Pearson v2 test or Fisher’s
exact test based on minimal cell count. Categorical data were
compared using an analysis of variance. For the primary out-
come (change in cognitive performance at 1 month as repre-
sented by the continuous, composite RCI values), we tested the
between-group difference (POD vs no POD) using the Mann–
Whitney U-test. Linear regression analysis was performed to
study the association between POD and change in cognitive per-
formance at 1 month and at 1 yr, adjusting for randomization to
dexamethasone or placebo, age, and level of education. To study
the association between preoperative cognitive tests and POD,
we tested the between-group difference (POD vs no POD) using
logistic regression analysis and adjusted for the same co-
variables. The analyses were performed using IBM SPSS version
21 (SPSS Inc., Chicago, IL, USA). All reported P-values were two
sided, and a significance level of P<0.05 was used.
Results
Between August 2010 and October 2011, 184 patients involved in
the delirium sub-study underwent the neuropsychological
preoperative baseline assessment. Of these, 176 (95.7%) com-
pleted the 1 month follow-up and 146 (79.3%) the 1 yr neuropsy-
chological follow-up. Of the 184 patients who completed the
baseline assessment, 23 (12.5%) patients developed delirium
during their postoperative hospital stay. In the POD group, one
patient died (5%) between the 1 month and 1 yr follow-up and
one refused follow-up (5%), so that the total number lost to
follow-up was two (9%). In the group without POD, three pa-
tients (2%) died and 25 (17%) refused follow-up; therefore, the
total number lost to follow-up was 28 (18%). Figure 1 shows the
enrolment flowchart and loss to follow-up.
Baseline patient, clinical, and surgical characteristics of the
176 patients who completed the 1 month follow-up are pre-
sented in Table 1. Patients who developed POD were signifi-
cantly older, more often had peripheral vascular disease, and
had a higher EuroScore compared with non-delirious patients.
The incidence of delirium and baseline characteristics, except
for serum creatinine and left ventricular function, were compar-
able between the group of patients with complete follow-up and
the group without 1 yr follow-up (data not shown).
Change in cognitive performance at 1 month
At 1 month, both patient groups showed a negative change in
cognitive performance, based on the composite RCI. The de-
crease in performance was significantly greater in patients who
had been delirious compared with those without delirium [me-
dian composite RCI 1.00, interquartile range (IQR) 1.67 to
0.28, vs 0.04, IQR 0.70 to 0.63; P¼0.02]. The unadjusted b was
0.99 [95% confidence interval (CI) 1.59 to 0.39, P¼0.001].
Adjusting for the possible confounders mentioned above with
multiple linear regression resulted in a b of 0.91 (95% CI 1.53
to 0.28, P¼0.005).
Change in cognitive performance at 1 yr
At 1 yr follow-up, positive median composite RCI scores were
found, indicating improved performance compared with the
preoperative baseline in both groups. The median composite
RCI score was less positive in patients who had POD (median
composite RCI 0.25, IQR 0.42 to 1.31) than in patients without
POD (0.92, IQR 0.18–1.53; P¼0.08), suggesting less improved
scores in the POD group, but this difference was not statistically
significant. Multivariable regression analysis did not change the
results (unadjusted b¼0.58, 95% CI 1.13 to 0.03; adjusted
b¼0.40, 95% CI 0.98 to 0.18; P¼0.17).
Postoperative delirium and postoperative scores on
individual neuropsychological tests
The raw neuropsychological test results at 1 month and 1 yr and
the adjusted changes from baseline are presented in Tables 2
and 3. Change from baseline in the grooved pegboard and the
Trailmaking test part B significantly differed between delirious
and non-delirious patients at both time points. In the POD
group, persistent decline was seen on the grooved pegboard,
and initially more severe decline recovering to minimal decline
was seen at the Trailmaking test part B compared with im-
proved performance on both tests in the non-delirious group.
Preoperative cognitive assessment and POD
As shown in Table 4, consistently lower preoperative scores
were recorded in the group who developed POD compared with
the group who did not. However, except for the Trailmaking test
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part A, these differences did not reach statistical significance
after adjusting for potential confounders.
Discussion
We assessed the relationship between POD and cognitive
change at 1 month after cardiac surgery and found that patients
with POD had a greater decline in cognitive performance than
those without POD. However, at 1 yr the patients with and with-
out POD showed an improved cognitive performance compared
with preoperative baseline cognitive levels, without a statistic-
ally significant difference between the two groups. Adjustment
for differences in age and level of education did not change the
results.
These findings are concordant with previous research, indi-
cating that POD is an independent risk factor for POCD in the
immediate postoperative trajectory.6–8 Previous studies on cog-
nitive function assessed after a longer duration of follow-up
were less consistent.6–8 In our study, we observed over the
course of 1 yr, on average, an improvement in cognitive per-
formance compared with baseline in patients with and without
POD.
The relationship between POD and POCD is complex and not
yet fully elucidated. Both entities share many risk factors, such
as increasing age, low level of education, and underlying co-
morbidities,1–5 8 and might be viewed as two expressions of the
same underlying process of pre-existing decreased cognitive re-
serve,23 as opposed to other evidence supporting a more inde-
pendent, possibly causal, relationship between delirium and
cognitive impairment.7 8 21 A causal relationship could have im-
portant clinical implications, because delirium would then be
one of the few modifiable risk factors for POCD, opening up pos-
sibilities for prevention. The magnitude of the influence of delir-
ium as an independent risk factor for POCD is difficult to
determine. Previous research in the field of POCD has already
shown that cognitive function may recover over time.6 8
Delirium might influence the speed and extent of recovery. In
the present study, both groups showed, on average, cognitive
improvement compared with baseline scores, but this effect
was less pronounced in the delirious group. Furthermore, we
did find consistent differences between both groups on the
grooved pegboard and Trailmaking test part B, indicating that
suffering from a delirium might especially influence fine motor
skills and executive functions. In the present study, we found








12 Months follow-up 126
Refused follow-up 1
1 Month follow-up 22
3Died
Refused follow-up 3
Withdrew informed consent 1
1 Month follow-up 154
4494 cardiac surgery patients randomized to dexamethasone or placebo in
the multicenter Dexamethasone for Cardiac Surgery trial
768 patients enrolled in the DECS trial in the UMC Utrecht
underwent additional delirium screening
291 patients enrolled in the DECS trial in the UMC Utrecht,
Erasmus MC and IsalaClinics underwent to additional
cognitive assessement
184 patients underwent additional delirium
screening and completed baseline cognitive
assessment
Fig 1 Enrolment flowchart.
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group that later on developed delirium. After adjusting for the
difference in age and education between both groups, the
Trailmaking test part A remained discriminative between both
groups, which might indicate that impaired attention at base-
line might predispose to development of delirium. Earlier stud-
ies on dysfunction in specific cognitive domains predictive for
the development of delirium did show an association with im-
pairment in executive functions tested with the Trailmaking
test part B24 and with more complex executive function tasks,25
which we were unable to find in the present study.
Our study had several strengths. We used a well-validated,
rigorous method of delirium detection, combining the results of
standardized observations by research personnel with data avail-
able from standard clinical patient care.14 This allowed us to cap-
ture the fluctuating nature of the condition. Staff availability
7 days per week enabled us to minimize missed observations and
Table 1 Patient, clinical, and surgical characteristics. *Data are shown as number of patients (percentages) or †median (interquartile
range). ‡The level of education was classified according to Dutch norm data using the system of Verhage, ranging from 1 (no education) to
7 (university). ¶Definition of myocardial infarction: the presence of new Q waves or a new left bundle branch block on the ECG, combined
with a biomarker (creatine kinase–MB or troponin) elevation of more than five times the upper reference limit. §Higher EuroScores present
increased risk of perioperative mortality.22 kDefinition of left ventricular function classes: moderate, ejection fraction of 30–50%; poor,
ejection fraction of< 30%. #Statistically significant. **Pearson v2. ††Fisher’s exact test. ‡‡Analysis of variance. COPD, chronic obstructive
pulmonary disease; CABG, coronary artery bypass grafting; ECG, electrocardiogram; MB, myocardial band
Characteristic Delirious (n¼22) Non-delirious (n¼154) P-value
Male sex* 12 (54.5) 115 (74.7) 0.05**
Age (yr)† 78.1 (74.6–82.7) 65.5 (57.0–72.2) <0.001#
Weight (kg)† 74.0 (63.0–84.0) 80.0 (71.0–90.0) 0.03#
Education†,‡ 5 (3–6) 5 (4–6) 0.81
Hypertension* 14 (63.6) 83 (53.9) 0.39**
Diabetes mellitus* 4 (18.2) 24 (15.6) 0.76††
COPD requiring treatment* 6 (27.3) 19 (12.3) 0.10††
Previous stroke* 3 (13.6) 9 (5.8) 0.18††
Peripheral vascular disease* 7 (31.8) 17 (11.0) 0.02#,††
Recent myocardial infarction*,¶ 0 (0.0) 9 (5.8) 0.60††
Serum creatinine (mmol litre1)† 87.5 (78.0–109.3) 91.5 (80.0–105.3) 0.64
EuroScore†,§ 8.0 (6.0–9.3) 4.0 (2.0–7.0) <0.001#
Left ventricular functionk 0.35‡‡
Moderate 2 (9.1) 32 (20.8)
Poor 1 (4.5) 3 (1.9)
Dexamethasone treatment* 8 (36.4) 75 (48.7) 0.36**
Type of surgery*
Isolated CABG 2 (9.1) 41 (26.6) 0.07**
Valve surgery 17 (77.3) 103 (66.9) 0.33**
Time to extubation (h)† 8.0 (6.8–12.3) 7.0 (6.0–10.0) 0.14
Cardiopulmonary bypass time (min)† 121.5 (89.5–154.5) 103 (77.0–152.5) 0.18
Cross-clamp time (min)† 92.0 (71.0–123.3) 78.0 (59.0–120.0) 0.17
Repeat surgery* 3 (13.6) 14 (9.1) 0.45††
Table 2 Raw neuropsychological test results at 1 month and change from baseline (z-score). *Positive values indicate improvement,
whereas negative values indicate decline in test performance. In timed tasks, lower scores reflect better performance. The RCI values of
these variables were inverted so that positive RCI values always indicate improvement and negative RCI values indicate decline in test
performance. †Statistically significant. P-values are for the adjusted z-scores and were calculated with multiple linear regression analysis.
IQR, interquartile range; RAVL, Rey auditory verbal learning; RAVL IR, Ray auditory verbal learning immediate recall; RAVL DE, Ray audi-
tory verbal learning delayed recall; RCI, Reliable Change Index; WAIS, Wechsler Adult Intelligence Scale
Test Delirious (n¼22) Not delirious (n¼154)
Raw score (IQR) Z-score (IQR) Raw score (IQR) Z-score (IQR) P-value
Corsi blocks (total score) 30 (23–36) 0.59 (0.93 toþ 0.30) 40 (35–54) 0.04 (0.57 toþ 0.36) 0.06
RAVL (IR) 34 (27–43) þ0.09 (0.63 toþ 1.23) 43 (34–50) þ0.26 (0.55 toþ 0.91) 0.55
RAVL (DR) 5 (4–7) þ0.15 (0.71 toþ 0.24) 8 (5–11) þ0.15 (0.61 toþ 0.53) 0.93
Grooved pegboard* (s) 105 (92–176 0.76 (1.7 toþ 0.57) 81 (69–96) þ0.08 (0.41 toþ 0.71) <0.001†
Trailmaking test A* (s) 48 (35–66) 0.03 (0.95 toþ 0.89) 34 (26–44) þ0.05 (0.41 toþ 0.35) 0.11
Trailmaking test B* (s) 84 (65–168) 0.67 (1.96 toþ 0.26) 58 (40–86) 0.06 (0.45 toþ 0.28) <0.001†
WAIS digit span (span) 5 (5–6) 0.12 (1.08 to 0.12) 5 (5–7) 0.12 (1.08 toþ 0.83) 0.32
WAIS digit span (total) 13 (11–14) 0.42 (1.32 toþ 0.46) 14 (12–16) 0.43 (1.32 toþ 0.46) 0.83
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ensure complete follow-up. For logistic reasons, we limited our
observation period to the first 4 days after surgery. Being a tertiary
centre, a significant part of the patient population with uncompli-
cated recovery returned to their referring centres within a week
after the surgery. This approach might have missed delirium that
developed later in the postoperative trajectory. The impact of this
limitation is likely to be small, because previous studies showed
that the vast majority of delirium in this population is clinically
apparent during the first 3 days after surgery.26 27 Our study popu-
lation was relatively young compared with other research in the
field, which may have resulted in a relatively low incidence of
POD. However, our incidence corresponds closely to a similar,
large trial by Katznelson and colleagues28 that reported an inci-
dence of 11.9% in 1528 cardiac patients.
Research on POCD has been hampered by the lack of consen-
sus on strict definitions for POCD based on neuropsychological
test methods.23 We chose a combination of neuropsychological
tests, covering a broad range of cognitive domains vulnerable for
postoperative change, including the core battery recommended
by the 1995 consensus statement.10 We presented a continuous
outcome to avoid arbitrary dichotomization and were able to
show improvement in performance. Furthermore, we corrected
for learning effects and natural fluctuation in test results by com-
paring our patients with a non-surgical control group who had
similar characteristics.21 Loss to follow-up was low, especially at
1 month, with a follow-up rate of 95.7%.
Our study has some limitations. The primary study outcome
and focus in our analysis was the change in cognitive perform-
ance from baseline to 1 month after surgery. Results from the
other analyses should be interpreted as hypothesis generating.
Overcorrection for learning might have occurred by using a con-
trol group with no intervention, who might not have been
exposed to the same amount of psychological stress, depres-
sion, or both at baseline, which is known to exist in cardiac sur-
gery patients in the period before their intervention. We did not
collect data on subjective patient outcomes and the experienced
burden of impairment. Therefore, we can make no statements
about the clinical impact of the cognitive decline that we meas-
ured with our neuropsychological test battery. We believe that
in general at 1 month follow-up, patients are still recovering
from their cardiac surgery, and the clinical relevance of POCD at
this follow-up moment might be limited. Like many other stud-
ies, our study suggests that perioperative factors might affect
cognitive performance in the first months after surgery, but not
in the long term. Including subjective assessments of postoper-
ative cognitive change at different time points in future re-
search might generate valuable information on the clinical
impact of the cognitive decline.
Table 3 Raw neuropsychological test results at 1 yr and change from baseline (z-score). *Positive values indicate improvement, whereas
negative values indicate decline in test performance. In timed tasks, lower scores reflect better performance. The RCI values of these vari-
ables were inverted so that positive RCI values always indicate improvement and negative RCI values indicate decline in test perform-
ance. †Statistically significant. P-values are for the adjusted z-scores and were calculated with multiple linear regression analysis. IQR,
interquartile range; RAVL, Rey auditory verbal learning; RAVL IR, Ray auditory verbal learning immediate recall; RAVL DE, Ray auditory
verbal learning delayed recall; RCI, Reliable Change Index; WAIS, Wechsler Adult Intelligence Scale
Test Delirious (n¼20) Not delirious (n¼126)
Raw score (IQR) Z-score (IQR) Raw score (IQR) Z-score (IQR) P-value
Corsi blocks (total score) 40 (35–42) þ0.29 (0.28 toþ 0.87) 54 (40–60) þ0.64 (0.00 toþ 1.04) 0.30
RAVL (IR) 38 (29–44) þ0.81 (0.32 toþ 1.13) 46 (35–54) þ0.65 (0.00 tþ 1.62) 0.81
RAVL (DR) 7 (5–10) þ0.76 (0.0 toþ 1.14) 9 (6–12) þ0.76 (0.00 toþ 1.14) 0.44
Grooved pegboard* (s) 99 (88–148) 0.56 (1.05 to 0.21) 77 (65–92) þ0.21 (0.28 toþ 0.63) 0.003†
Trailmaking test A* (s) 46 (34–63) 0.04 (0.58 toþ 0.83) 35 (28–47) 0.08 (0.32 toþ 0.38) 0.97
Trailmaking test B* (s) 86 (55–152) 0.06 (0.96 toþ 0.59) 51 (36–73) þ0.17 (0.17 toþ 0.66) 0.03†
WAIS digit span (span) 5 (5–6) 0.00 (0.96 toþ 0.72) 6 (5–7) 0.00 (0.96 toþ 0.96) 0.95
WAIS digit span (total) 14 (12–15) 0.00 (0.44 toþ 1.33) 15 (13–18) þ0.44 (0.44 toþ 1.33) 0.56
Table 4 Neuropsychological test results at baseline. *In timed tasks, lower scores reflect better performance. †Statistically significant. CI,
confidence interval; IQR, interquartile range; OR, odds ratio; RAVL, Rey auditory verbal learning; RAVL IR, Ray auditory verbal learning
immediate recall; RAVL DE, Ray auditory verbal learning delayed recall; WAIS, Wechsler Adult Intelligence Scale
Delirious (IQR) Not delirious (IQR) Unadjusted (95% CI) P-value Adjusted (95% CI) P-value
Test (n¼22) (n¼154) OR OR
Corsi blocks (total score) 33 (24–42) 40 (30–48) 0.97 (0.94–1.01) 0.09 0.99 (0.95–1.03) 0.54
RAVL (IR) 34 (26–37) 39 (32–47) 0.94 (0.89–0.98)† 0.01 0.98 (0.92–1.04) 0.50
RAVL (DR) 5 (3–7) 7 (5–10) 0.76 (0.64–0.90)† 0.002 0.85 (0.70–1.04) 0.11
Grooved pegboard* (s) 102 (86–158) 85 (72–102) 1.02 (1.01–1.03)† 0.001 1.01 (0.99–1.02) 0.31
Trailmaking test A* (s) 52 (39–60) 37 (28–47) 1.06 (1.03–1.09)† <0.001 1.04 (1.00–1.09)† 0.03
Trailmaking test B* (s) 90 (53–113) 61 (41–90) 1.01 (1.00–1.02)† 0.03 1.00 (0.99–1.02) 0.71
WAIS digit span (span) 6 (5–6) 6 (5–7) 0.85 (0.60–1.22) 0.38 0.76 (0.45–1.15) 0.16
WAIS digit span (total) 13 (11–15) 14 (11–17) 0.93 (0.82–1.05) 0.22 0.90 (0.78–1.04) 0.16
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In conclusion, this study showed that POD is independently
associated with cognitive decline 1 month after surgery.
Secondary outcomes indicate that POD is not associated with
cognitive decline 1 yr after surgery and that cognitive perform-
ance generally recovers in the year after the operation, except
for the specific cognitive domains of motor skills and executive
function. Patients with a predisposition to POD are character-
ized by worse performance in attention-requiring tasks.
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